Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
Madrigal Pharmaceuticals granted inducement equity awards to seven new non-executive employees on July 1, 2026, approved by its independent Compensation Committee under Nasdaq Listing Rule 5635(c)(4). The awards consist of options to purchase 604 shares of common stock and 2,952 time-based restricted stock units, with an exercise price equal to the closing price of $514.39 per share on the grant date.
Key figures
- Rsus units
- 2952
- Exercise price
- 514.39
- Options shares
- 604
- New employees count
- 7
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.